Search results for "Confer"

showing 10 items of 286 documents

Los Gs auxiliares del imperio

2005

MiembrosFranciaVidal-Beneyto JoséImperioIndustrias de la informaciónSistema MonetarioCrisisGGsGATTPublicaciones: Obra periodística: Columnas y artículos de opiniónPODERPaíses no alineadosAmérica LatinaGlobalizaciónRelaciones públicasPlanetaGrandes decisionesAfganistánReino UnidoOrden económico MundialPolítica institucionalTercer MundoAlemania OccidentalForo de DavosConferencias internacionalesConcienciaEconomías emergentesFinanzasEE UURepresentatividad globalGobernanzaEmpleo
researchProduct

I Modelli di Equazioni Strutturali: Temi e prospettive

2013

Modelli di equazioni strutturaliModerazioneMediazioneAnalisi fattoriale confermativa
researchProduct

Una rampa de lanzamiento

2001

MundializaciónComisión EuropeaVidal-Beneyto JoséEuroPOLÍTICAConferencia IntergubernamentalEUROPAVoluntarismoLiderazgoPublicaciones: Obra periodística: Columnas y artículos de opiniónUnión EuropeaLegitimidad democráticaEstados miembrosParlamento EuropeoConsejo EuropeoNizaPresidencia europeaCrisis económica
researchProduct

NUOVE PROSPETTIVE IN MATERIA DI CONFERIMENTI IN NATURA NELLE SOCIETÀ PER AZIONI

2012

NATURASOCIETÀ PER AZIONICONFERIMENTISettore IUS/04 - Diritto Commerciale
researchProduct

Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant …

2020

Although liver transplantation (LT) is the best treatment for patients with localized hepatocellular carcinoma (HCC), recurrence occurs in 6%-18% of patients. Several factors, particularly morphological criteria combined with dynamic parameters, known before LT modify this risk and combined in prediction models may be used to stratify patients at need of variable surveillance strategies. Additional variables though likely explain differences in recurrence rates in patients with the same pre-LT HCC status. One of these variables is possibly immunosuppression (IS). Once recurrence takes place, management is highly heterogenous. Within the International Liver Transplantation Society Consensus …

OncologyAblation Techniquesmedicine.medical_specialtyCarcinoma HepatocellularConsensusmedicine.medical_treatmentConsensus Development Conferences as TopicMEDLINE030230 surgeryLiver transplantationMedical OncologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansIn patientGrading (tumors)Societies MedicalPostoperative CareTransplantationbusiness.industryLiver NeoplasmsConsensus conferenceImmunosuppressionChemoradiotherapy Adjuvantmedicine.diseasePrognosisUnited StatesLiver TransplantationQuality of evidenceEuropeTreatment OutcomeHepatocellular carcinomaPractice Guidelines as Topic030211 gastroenterology & hepatologyNeoplasm Recurrence Localbusiness
researchProduct

GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012

2013

In 2006, under the auspices of The Spanish Research Group for Ovarian Cancer (Spanish initials GEICO), the first “Treatment Guidelines in Ovarian Cancer” were developed and then published in Clinical and Translational Oncology by Poveda Velasco et al. (Clin Transl Oncol 9(5):308–316, 2007). Almost 6 years have elapsed and over this time, we have seen some important developments in the treatment of ovarian cancer. Significant changes were also introduced after the GCIG-sponsored 4th Consensus Conference on Ovarian Cancer by Stuart et al. (Int J Gynecol Cancer 21:750–755, 2011). So we decided to update the treatment guidelines in ovarian cancer and, with this objective, a group of investigato…

OncologyCancer Researchmedicine.medical_specialtyFirst lineConsensus Development Conferences as TopichumanosGuidelines as TopicOvarian cancerInternal medicineguías como asuntoRecurrent diseasemedicineTreatment guidelinesChemotherapyRecurrent diseaseHumansreuniones de consenso como asuntoGynecologyOvarian NeoplasmsTranslational oncologybusiness.industryConsensus conferenceCancerneoplasias ováricasGeneral Medicinemedicine.diseaseFirst lineOncologySpainEducational Series - Red SeriesSurgeryFemaleOvarian cancerbusinessClinical & Translational Oncology
researchProduct

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/Wo…

2010

The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC. 21 Suppl 6 vi1 10

OncologyColorectal cancermedicine.medical_treatmentBraf proteinGastroenterologyMetastasisDrug antagonismTargeted therapyMetastasisAntineoplastic agentsPathologyConference paperBiological markersPredictive markerHematologyPrognosisChemotherapy regimenAntineoplastic agentOncologyProto-oncogene proteinsRas proteinHumanReceptormedicine.medical_specialtyNeoplasm metastasisRas proteinsMEDLINEOncoproteinColorectal neoplasmsProto-oncogene proteins b-rafInternal medicineGeneticsmedicineHumansGastrointestinal cancerColorectal tumorB raf kinaseEpidermal growth factor receptorKras proteinbusiness.industryEpidermal growth factorCancermedicine.diseasedigestive system diseasesBiological markerMetabolismSpainMutationCarcinoembryonic antigenMicrosatellite instabilitybusinessAnnals of Oncology
researchProduct

Definition and management of colorectal polyposis not associated with APC/MUTYH germline pathogenic variants: AIFEG consensus statement

2021

An expert consensus panel convened by the Italian Association for Inherited and Familial Gastrointestinal Tumors (Associazione Italiana per lo Studio della Familiarita ed Ereditarieta dei Tumori Gastrointestinali, AIFEG) reviewed the literature and agreed on a number of position statements regarding the definition and management of polyposis coli without an identified pathogenic mutation on the APC or MUTYH genes, defined in the document as NAMP (non-APC/MUTYH polyposis).

Oncologymedicine.medical_specialtyGastrointestinal tumorsColorectal cancerSurgical ManagementColorectal polyposisGermline03 medical and health sciencesCancer Genetic0302 clinical medicineMUTYHInternal medicinemedicineCancer GeneticsPolyposis coliHepatologyPathogenic mutationbusiness.industryColorectal polyposis not associated with APC/MUTYH mutationPolyposis management guidelineGastroenterologyExpert consensusEndoscopic surveillancemedicine.diseaseColorectal cancerConsensus development conference030220 oncology & carcinogenesisCancer Genetics; Colorectal cancer; Colorectal polyposis not associated with APC/MUTYH mutation; Consensus development conference; Endoscopic surveillance; Polyposis management guideline; Surgical Management030211 gastroenterology & hepatologybusiness
researchProduct

Gene Expression Analyses in Early Breast Carcinoma — Quo Vadis?

2017

AbstractIn order to establish whether adjuvant therapy should be administered in patients with breast carcinoma, it is decisive to have as precise as possible an assessment of the risk of recurrence. In this context, gene expression — and thus gene expression signatures as well — have become a focus of attention as prognostic factors. For practical application, it is important to be able to analyze gene expression signatures in formalin-fixed, paraffin-embedded tumor tissue. Careful analytic and clinical validations and a high level of evidence (LoE) are required in order to avoid imprecise risk classification and thus potential overtreatment or undertreatment of the patients. Among the com…

Oncologymedicine.medical_specialtybusiness.industryConsensus conferenceContext (language use)Evidence-based medicinemedicine.diseaseBreast cancerInternal medicineGene expressionmedicineAdjuvant therapybusinessProspective cohort studyBreast carcinomaSenologie - Zeitschrift für Mammadiagnostik und -therapie
researchProduct

Multiple Forms of Professional Agency for (non)crafting of Work Practices in a Hospital Organization

2015

In recent working life studies, professional agency is seen as pivotal to the development of work communities and work organizations. This paper addresses professional agency during a practicebased intervention (work conference) in a Finnish hospital setting. To develop work practices, the intervention sought to create a dialogical space for the promotion of collective professional agency. Here, we present an investigation of the manifestations of professional agency and how they emerged within and between professional groups. We also elaborate how professional positions frame the emergence of different manifestations of professional agency. The audio and video materials from the interventi…

Organizational Behavior and Human Resource Managementmeaning & culturemedia_common.quotation_subjectwork conferenceeducationworking environment & wellbeinglcsh:Labor. Work. Working classLearning & compentenciesProfessional studiesPromotion (rank)Organization developmentIdentityIntervention (counseling)Agency (sociology)Organization & managementSociologyLife-span and Life-course Studieshealth care economics and organizationsmedia_commonetnografiabusiness.industrylcsh:HD4801-8943Dialogical selfPublic Health Environmental and Occupational Healthemergency unitprofessional agencyPublic relationshumanitiesTransformative learningHealthIndustrial relationsbusinessMeaning (linguistics)Nordic Journal of Working Life Studies
researchProduct